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A CASE OF SYNCHRONOUS TRIPLE PRIMARY CARCINOMAS 
OF THE KIDNEY， BLADDER AND PROST ATE 
Hiroyuki SATOH， Tetsuo MOMMA and Shiro SAITO 
From the Dψar加 ent01 Urology， National Tokyo Medical Center 
Shigemichi HIROSE 
From the Department 01 Pathology， National Tokyo Medical Center 
A case of synchronous triple carcinomas arising in the kidney， bladder and prostate is reported. 
An 82・year-oldman had gross hematuria. Urine cytology was positive and intravenous pyelography 
showed right hydronephrosis with a filling defect in the bladder. Computed tomography revealed a 
4 cm mass in the blader， enlarged prostate and 6 cm renal mass at the left kidney. Cystoscopy 
demonstrated a papillary broadbased tumor with some small satellite tumors in the bladder， and 
magnetic resonance imaging revealed muscle invasion ofthe bladder tumor. This patient underwent 
left radical nephrectomy and total cystoprostatectomy with ileal conduit urinary diversion as radical 
treatment. Histological diagnosis was renal cel carcinoma， transitional cell carcinoma ofthe bladder. 
Furthermore， well-differentiated adenocarcinoma was found incidentally in the prostate. 
Immunohistochemical staining with anti-p53 antibody for the three tumors showed positive 
staining only for the bladder cancer. 
(Acta Urol. Jpn. 49: 261-264， 2003) 




































腎下極腹側に径 6cmの腫蕩が確認された (Fig.2). 
跨脱癌の転移か原発性腎癌の鑑別のため血管造影を施
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Fig. 1. CT revealed a 6 cm mass with contrast 
enhancement at the left kidney 
(arrow) 
Fig. 2. MRI revealed 4 cm mass with bladder 

















病理診断では，腎臓は RCC，clear cel + alveolar 
cel subtype， G2， INFs， V (一)， pT3a，腸脱は
TCC， sarcomatoid carcinoma， G3，乳頭状浸i閏
型， INFa， pT2， pRO， pLO， pVO， pNOであっ
たが，前立腺よりも welldifferentiated adenocarci-
noma， Gleason's score 2 + 2 = 4， pT2a， Int 2， Iy 
(C) 
Fig. 3. The H-E staining. (A) renal cel car-
cinoma， (B) transitional cel carcinoma 
of urinary bladder and (C) prostate well-
differen tiated adenocarcinoma (X 100). 
(一)， v (一)， pn (+)， dw (+) ， INFαcap 
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The p53 immunohistochemical stain-
ing， (A) renal cel carcinoma， (B) 
transitional cell carcinoma of urinary 
bladder and (C) prostate well-differen-
tiated adenocarcinoma， Bladder car-

























































30-60%23、25) 前立腺癌では 6-21 %26、28)と報告さ
れており， p53の変異の臨床的意義については次のよ
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